Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Other material event · Financial statements
FATE THERAPEUTICS INC
39
Other material event
Jun 4, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Financial statements |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | FATE THERAPEUTICS INC filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. 1 TRANSFORMING THE LIVES OF PATIENTS LIV ING WITH AUTOIMMUN E DISEASES AND C ANCER Making Cell Therapies Accessible to AllTM CORPORATE PRESENTATION June 2026 | NASDAQ: FATE | Non-Confidential © 2026 Fate Therapeutics. All rights reserved Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the Private… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 4, 2026 |
| Accession number | 0001193125-26-257558 |
| Reported items | Other events the company considers material, Financial statements and exhibits See Analysis tab for workforce implications |
